AI Generated Image
Blood pressure medication recalled nationwide over manufacturing issue
KOMO • • business
Key Points:
- Inventia Healthcare Limited has voluntarily recalled over 11,000 bottles of Chlorthalidone Tablets USP, 25 mg, due to a manufacturing issue affecting the medication's dissolution properties.
- The recall includes 100-count and 1,000-count bottles distributed in the U.S. by Rising Pharma Holdings Inc., specifically lot numbers RISA24001 and RISB24002, both expiring in April 2027.
- The recalled tablets may not dissolve properly in the body, potentially impacting their effectiveness in treating high blood pressure and fluid retention.
- The FDA has not yet classified the recall or issued a public notice, and patients are advised to consult healthcare providers before making any changes to their medication.
